CXCL8 and neoplasm: As many of the secreted mediators from EMT-activated tumors are established chemoattractants of neutrophils (GRO, CXCL8, GM-CSF) and monocytes (CCL2), the release of these mediators upon EMT induction is poised to regulate the immune landscape of the tumor niche.